Abstract

Journal of Pharmacy Practice and ResearchVolume 34, Issue 4 p. 259-261 EditorialFree Access Pharmacist Prescribing—Lessons from Abroad Olivia Kay BPharm, Olivia Kay BPharm olivia.kay@email.cs.nsw.gov.au Pharmacy Department Royal Prince Alfred Hospital Camperdown NSW 2050 AustraliaSearch for more papers by this authorJo-anne Brien BPharm, BS(Pharm), PharmD, Jo-anne Brien BPharm, BS(Pharm), PharmD Pfizer Australia Chair in Clinical Pharmacy (St Vincent's Hospital) jebrien@pharm.usyd.edu.au The University of Sydney Camperdown NSW 2006 AustraliaSearch for more papers by this author Olivia Kay BPharm, Olivia Kay BPharm olivia.kay@email.cs.nsw.gov.au Pharmacy Department Royal Prince Alfred Hospital Camperdown NSW 2050 AustraliaSearch for more papers by this authorJo-anne Brien BPharm, BS(Pharm), PharmD, Jo-anne Brien BPharm, BS(Pharm), PharmD Pfizer Australia Chair in Clinical Pharmacy (St Vincent's Hospital) jebrien@pharm.usyd.edu.au The University of Sydney Camperdown NSW 2006 AustraliaSearch for more papers by this author First published: 01 December 2004 https://doi.org/10.1002/jppr2004344259Citations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Carmichael JM, O'Connell MB, Devine B, Kelly HW, Ereshefsky L, Linn WO, Stimmel GL. Collaborative drug therapy management by pharmacists: American college of clinical pharmacy. Pharmacotherapy. 1997: 17: 1050– 61. 2Weeks GR. Pharmacist prescribing; let's have the debate. J Phann Pract Res: 2004; 34 4– 5 3Koch KE. Trends in collaborative drug therapy management. Drug Benefit Trends 2000; 12: 45– 54. 4Reichert SL. Developing a protocol for collaborative drug therapy management. Am J Health Syst Phann 1999; 56: 1715– 7. 5Eng HJ, McCormick WC. Assessment of the Florida pharmacist self-care consultant law using patient profile and prescription audit methods. Drug Intell Clin Phann 1990; 24: 931– 5. 6Child D, Cantrill JA. Hospital doctors' perceived barriers to pharmacist prescribing. Int J Phann Pract 1999; 7: 230– 7. 7Segal R, Grines LL. Prescribing authority for pharmacists as viewed by organized pharmacy, organized medicine, and the pharmaceutical industry. Drug Intell Clin Pharm 1988; 22: 241– 6. 8St Jean Wittenburg A. Obtaining prescribing authority for pharmacists: lessons learned. Am J Health Syst Pharm 1995; 52: 1616–. 9 Anonymous. No obstacle to pharmacists prescribing. Pharm J 2002; 269: 450–. 10Farrell J, North-Lewis P, Cross M. Pharmacist prescribing in the United States. Pharm J 1997; 259: 187– 90. 11Chi J. Power of pen: pharmacist prescribing is advancing slowly but surely throughout the country. Drug Topics 2000; 144: 39– 40. 12Bellingham C. Space, time and team working: issues for pharmacists who wish to prescribe. Pharm J 2002; 268: 562– 3. 13Galt KA. The key to pharmacist prescribing: collaboration. Am J Health Syst Pharm 1995; 52: 1696– 9. 14Webb CE. Prescribing medications: changing the paradigm for a changing health care system. Am J Health Syst Pharrn 1995; 52: 1693– 5. Citing Literature Volume34, Issue4December 2004Pages 259-261 ReferencesRelatedInformation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call